Related Experiment Video
Updated: Feb 10, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
1Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Abstract:
Mass spectrometry methods that can detect low levels of monoclonal immunoglobulin in serum have recently been developed. These assays are based on the principle that each immunoglobulin has a unique amino acid sequence and therefore, has a unique mass. This mass can be used as a surrogate marker in order to monitor a patient's disease over time and at low levels. Here, we explain these methods, discuss their advantages and disadvantages and how they may be used to monitor monoclonal immunoglobulins for minimal residual disease detection in multiple myeloma.
Related Concept Videos
Mass Spectrometry: Overview
Tandem Mass Spectrometry
Mass Spectrometry of Amines
Mass Spectrometry: Isotope Effect
Chemical Ionization (CI) Mass Spectrometry
Mass Spectrometry: Alkene Fragmentation

